PATENT CLAIM ANALYSIS

Application Number: 15993287
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-12
Patent Classification: ["514", "04400A"]

Abstract:
Antisense oligomer conjugates complementary to a selected target site in the human dystrophin gene to induce exon 52 skipping are described.

Claim (Index 6):
An antisense oligomer conjugate of Formula (II): or a pharmaceutically acceptable salt thereof, wherein each Nu from 1 to 25 and 5\u2032 to 3\u2032 is: Position No. 5\u2032 to 3\u2032 Nu 1 C 2 X 3 G 4 X 5 X 6 C 7 C 8 A 9 A 10 A 11 X 12 C 13 C 14 X 15 G 16 C 17 A 18 X 19 X 20 G 21 X 22 X 23 G 24 C 25 C and wherein A is C is G is and each X is independently

Metadata:
- Claim Count in Document: 47.0
- Percentile: 93.0
- Lexical Diversity: 1.04762
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13219401', '14240832', '14368307', '15339069', '13307926']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8154063707122581
- 35 USC 102 Novelty (BERT): 0.5418407209116813
- Combined Prediction Score: 0.7880498057322004
- Mean Citation Score: 388.39622
- Max Citation Score: 426.69928
- Similarity Product: 253.7431997588444

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test